We use cookies on our website to make it clear, useful and reliable.In order to achieve this and to provide certain personalised features we store a small amount of data about you. To learn more Click Here. By navigating from the front page to other sections of our website, you are consenting to information being stored.
Our latest news & events
Parallel™ is the first prescription only digital therapeutic to provide cognitive behavioural therapy (CBT) to adults with irritable bowel syndrome (IBS) to receive the FDA Marketing Authorization in the US. ParallelTM has also obtained a CE mark and been recommended for Evaluation in Practice by the National Institute for Health and Care Excellence (NICE).
By NIHR Maudsley BRC at 1 Apr 2021
King's College London part of major new research project exploring role of immune cells in Alzheimer's Disease.
By NIHR Maudsley BRC at 11 Jan 2017A new tool to help pregnant women make decisions about antidepressant medication is being developed and tested.
By NIHR Maudsley BRC at 29 Jun 2016Dr Nilay Hepgul tells us about the latest findings from the PROMPT project which is profiling people who use psychological therapy services.
By NIHR Maudsley BRC at 16 Mar 2016
The National Institute for Health Research (NIHR) Maudsley Biomedical Research Centre (BRC) at South London and Maudsley NHS Foundation Trust and King’s College London. We are part of King’s Health Partners Academic Health Sciences Centre.
